Simplex Trading’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,505
Closed -$11.6K 9232
2023
Q4
$9K Buy
+10,505
New +$7.76K ﹤0.01% 7511
2023
Q2
Sell
-100
Closed -$125 9327
2023
Q1
$0 Sell
100
-60,245
-100% -$115K ﹤0.01% 9411
2022
Q4
$130K Buy
60,345
+39,557
+190% +$326K ﹤0.01% 4756
2022
Q3
$249K Buy
20,788
+550
+3% +$6.83K ﹤0.01% 4331
2022
Q2
$169K Buy
20,238
+17,328
+595% +$134K ﹤0.01% 4828
2022
Q1
$25K Sell
2,910
-13,119
-82% -$127K ﹤0.01% 7988
2021
Q4
$181K Buy
+16,029
New +$190K ﹤0.01% 5332
2021
Q2
Sell
-5,267
Closed -$45.7K 10267
2021
Q1
$48K Sell
5,267
-11,639
-69% -$117K ﹤0.01% 6667
2020
Q4
$163K Buy
16,906
+5,017
+42% +$49.4K ﹤0.01% 4875
2020
Q3
$147K Buy
11,889
+7,635
+179% +$101K ﹤0.01% 4480
2020
Q2
$55K Sell
4,254
-38,601
-90% -$485K ﹤0.01% 5402
2020
Q1
$434K Buy
+42,855
New +$560K ﹤0.01% 2742
2019
Q4
Sell
-3,321
Closed -$66.9K 7519
2019
Q3
$55K Buy
+3,321
New +$66K ﹤0.01% 4927

Other funds holding GOSS

Simplex Trading's GOSS Position: Q1 2024 in Review

Simplex Trading sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 10,505 shares — an estimated $11.6K sold.

Simplex Trading first reported a position in GOSS in Q3 2019 and held it in 13 quarters. The position peaked at $434K in Q1 2020. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Simplex Trading reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 10,505 Gossamer Bio shares in Q1 2024, an estimated $11.6K.
  • Simplex Trading first reported a position in Gossamer Bio in Q3 2019 and held it in 13 quarters.
  • Simplex Trading's Gossamer Bio position peaked at $434K in Q1 2020.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.